CVE-2021-26726
HIGH
Published Feb 16, 20224y ago · Modified Jun 17, 20262w ago
8.8 CVSS 3.1
Published Feb 16, 2022 4y ago
Last Modified Jun 17, 2026 2w ago
Description
A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.
CVSS Details
Base Score
Exploitability
Impact
Vector string
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H Attack Vector Adjacent
Attack Complexity Low
Privileges Required None
User Interaction None
Scope Unchanged
Confidentiality High
Integrity High
Availability High
Threat Intelligence
No active exploitation signals — not in CISA KEV and no EPSS score yet.
Exploit & Patch Status
No Known Exploit
No Patch Available
Weaknesses 5
CWE-209
CWE-272
CWE-305
CWE-330
CWE-78 OS Command Injection Injection
Affected Products 1
| Vendor | Product | Version | Range |
|---|---|---|---|
| valmet | dna | * | ≥2012 – ≤2021 |
References 2
- nozominetworks.com https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/
- valmet.com https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisories/
Remediation
No remediation data recorded yet
Check vendor advisories and the NVD entry for patch availability.